Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|October 23, 2012
Postoperative radiation for prostate cancerJason A Efstathiou
Seminars in Radiation Oncology|December 18, 2016
IntroductionJason A Efstathiou
Nature Reviews. Urology|February 13, 2013
Prostate cancer: Proton therapy--revolutionary advance or diminishing returns?Phillip J Gray, Jason A Efstathiou
JAMA|November 9, 2015
Treatment Trends for Prostate CancerJustin C Voog, Jason A Efstathiou
Urology|November 11, 2019
EDITORIAL COMMENTAbhishek A Solanki, Jason A Efstathiou
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Immunotherapy and Radiation - A New Combined Treatment Approach for Bladder Cancer?Zachary S Buchwald, Jason A Efstathiou
Seminars in Radiation Oncology|December 14, 2022
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North AmericaSophia C Kamran, Jason A Efstathiou
European Urology|December 11, 2012
Words of wisdom. Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancerJason A Efstathiou, William U Shipley
Urology|February 21, 2019
Editorial commentTrevor J Royce, Jason A Efstathiou
European Urology|April 8, 2015
Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerZachary S Buchwald, Jason A Efstathiou
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|October 23, 2012
Postoperative radiation for prostate cancerJason A Efstathiou
Seminars in Radiation Oncology|December 18, 2016
IntroductionJason A Efstathiou
Nature Reviews. Urology|February 13, 2013
Prostate cancer: Proton therapy--revolutionary advance or diminishing returns?Phillip J Gray, Jason A Efstathiou
JAMA|November 9, 2015
Treatment Trends for Prostate CancerJustin C Voog, Jason A Efstathiou
Urology|November 11, 2019
EDITORIAL COMMENTAbhishek A Solanki, Jason A Efstathiou
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Immunotherapy and Radiation - A New Combined Treatment Approach for Bladder Cancer?Zachary S Buchwald, Jason A Efstathiou
Seminars in Radiation Oncology|December 14, 2022
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North AmericaSophia C Kamran, Jason A Efstathiou
European Urology|December 11, 2012
Words of wisdom. Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancerJason A Efstathiou, William U Shipley
Urology|February 21, 2019
Editorial commentTrevor J Royce, Jason A Efstathiou
European Urology|April 8, 2015
Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerZachary S Buchwald, Jason A Efstathiou
Pageof 28